Are bone defects in rare patients with Glanzmann's thrombasthenia associated with ITGB3 or ITGA2B mutations?

References

• Holt I, Marshall MJ. Integrin subunit β3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface. Journal of Cell Physiology 1998; 175: 1–9
   Google Scholar
• Boissy P, Machuca I, Pfaff M, Ficheux D, Juric P. Aggregation of mononucleated precursors triggers cell surface expression of αvβ3 integrin, essential to formation of osteoclasts-like multinucleated cells. Journal of Cell Science 1998; 111: 2563–2574
   Google Scholar
• Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL. A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. Journal of Clinical Investigation 1997; 99: 2284–2292
   PubMed Web of Science ®Google Scholar
• Hodilvala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. Journal of Clinical Investigation 1999; 103: 229–238
   PubMedGoogle Scholar
• McHugh KP, Hodilvala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. Journal of Clinical Investigation 2000; 105: 433–440
   PubMed Web of Science ®Google Scholar
• Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL. A Glanzmann's mutation in β3 integrin specifically impairs osteoclast function. Journal of Clinical Investigation 2001; 107: 1137–1144
   PubMed Web of Science ®Google Scholar
• Morgan EA, Schneider JG, Baroni TE, Uluçkan O, Heller E, Hurchla MA, Deng H, Floyd D, Berdy A, Prior JL, et al. Dissection of platelet and myeloid cell defects by conditional targeting of the β3-integrin subunit. FASEB Journal 2010; 24: 1117–1127
   PubMedGoogle Scholar
• Tropel P, Roullot V, Vernet M, Poujol C, Pointu H, Nurden P, Marguerie G, Tronik-Le Roux D. A 2.7-kb portion of the 5′ flanking region of the murine glycoprotein αIIb gene is transcriptionally active in primitive hematopoietic progenitor cells. Blood 1997; 90: 2995–3004
   PubMed Web of Science ®Google Scholar
• Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann's thrombasthenia in Israel. Blood 1991; 77: 75–83
   PubMed Web of Science ®Google Scholar
• Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 3160–3164
   PubMed Web of Science ®Google Scholar
• Horton MA, Massey HM, Rosenberg N, Nicholls B, Seligsohn U, Flanagan AM. Upregulation of osteoclast α2β1 integrin compensates for lack of αvβ3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. British Journal of Haematology 2003; 122: 950–957
   Google Scholar
• Kunicki TJ, Nugent DJ. The genetics of normal platelet reactivity. Blood 2010; 116: 2627–2634
   PubMed Web of Science ®Google Scholar
• Yarah N, Fisgin T, Duru F, Kara A. Osteopetrosis and Glanzmann's thrombasthenia in a child. Annals of Hematology 2003; 82: 254–256
   Google Scholar
• Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R, Etzioni A, Alon R. Kindlin-3: A new gene involved in the pathogenesis of LAD-III. Blood 2008; 112: 2591–2592
   Google Scholar
• Schlegelberger B, Grote W, Wiedemann HR. Probable autosomal recessive syndrome with triphalangia of thumbs, thrombasthenia Glanzmann and deafness of internal ear. Klinische Padiatrie 1986; 198: 337–339
   Google Scholar
• Nelson EJR, Li J, Mitchell WB, Chandy M, Srivastava A, Coller BS. Three novel β-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-αIIb, but variably impaired progression of pro-αIIbβ3 from endoplasmic reticulum to Golgi. Journal of Thrombosis and Haemostasis 2005; 3: 2773–2783
   PubMed Web of Science ®Google Scholar
• Wilcox DA, Paddock CM, Lyman S, Gill JC, Newman PJ. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Journal of Clinical Investigation 1995; 95: 1553–1560
   PubMed Web of Science ®Google Scholar
• Ferrer M, Fernandez-Pinel M, Gonzalez-Manchon C, Gonzalez J, Ayuso M, Parilla R. A mutant (Arg327->His) GPIIb associated to thrombasthenia exerts a dominant negative effect in stably transfected CHO cells. Thrombosis and Haemostasis 1996; 76: 292–301
   PubMedGoogle Scholar
• Kannan M, Ahmad F, Yadav BK, Kumar R, Choudhry VP, Saxena R. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia. Journal of Thrombosis and Haemostasis 2009; 7: 1878–1885
   PubMed Web of Science ®Google Scholar
• Vinciguerra C, Bordet JC, Beaune G, Grenier C, Dechavanne M, Négrier C. Description of 10 new mutations in platelet glycoprotein IIb (αIIb) and glycoprotein IIIa (β3) genes. Platelets 2001; 12: 486–495
   Web of Science ®Google Scholar
• Tucci M, De Palma R, Lombardi L, Rodolico G, Berrino L, Dammacco F, Silvestris F. β3 integrin subunit mediates the bone resorbing function exerted by cultured myeloma plasma cells. Cancer Research 2009; 69: 6738–6746
   PubMed Web of Science ®Google Scholar
• Nurden AT, Didry D, Kieffer N, McEver RP. Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia. Blood 1985; 65: 1021–1024
   PubMed Web of Science ®Google Scholar
• Nurden AT, Kunicki TJ, Nurden P, Fiore M, Martins N, Heilig R, Pillois X. Mutation analysis for a patient with Glanzmann thrombasthenia who produced a landmark isoantibody to the αIIbβ3 integrin. Journal of Thrombosis and Haemostasis, 2010; 8: 1866–1868
   Google Scholar